Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Genetically modified serotype 5/3 adenovirus coding for granulocyte-macrophage colony-stimulating factor

EU orphan designation number: EU/3/13/1145   
Active ingredient: Genetically modified serotype 5/3 adenovirus coding for granulocyte-macrophage colony-stimulating factor
Indication: Treatment of soft tissue sarcoma
Sponsor: Targovax Oy
Saukonpaadenranta 2, 00180 Helsinki, Suomi

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/06/2013 Orphan designation EMA/OD/041/13 (2013)3966 of 19/06/2013
05/11/2015 Change of name and/or address of sponsor